World Sleep Industry ENCYCLOPEDIA

Baizi Yangxin Pills

2.1.2

Finished-product identity and thirteen-ingredient formula

Baizi Yangxin Pills is the name of a registered Chinese patent medicine in WSIC 2.1.2. The current pharmacopoeial pill formula contains thirteen ingredients: arborvitae seed, Codonopsis root, honey-fried astragalus root, Sichuan lovage rhizome, Chinese angelica root, poria, prepared polygala root, sour jujube seed, cinnamon bark, vinegar-processed schisandra fruit, processed pinellia ferment, honey-fried licorice, and cinnabar. Its registered traditional function is to supplement qi, nourish blood, and calm the spirit for a pattern described as cold deficiency of heart qi with palpitations, being easily startled, insomnia with many dreams, and forgetfulness. These are traditional function and pattern terms, not a modern causal diagnosis.

Baizi Yangxin Pills must be distinguished from Tianwang Buxin Pills, Anshen Buxin products, Baizi Yangxin tablets or capsules, single-ingredient arborvitae seed, and modified decoctions. A similar name or shared ingredients such as sour jujube seed and schisandra does not establish the same proportions, processing, cinnabar content, excipients, quality standard, or regulatory identity. Confirm the generic name, dosage form, approval number, marketing authorization holder, and complete ingredient panel on the physical package instead of selecting a product by a retail title or colloquial name.

Dosage form, strength, and label priority

The pharmacopoeial monograph covers water-honey pills, small honey pills, and large honey pills, with directions expressed in grams or pill counts according to the dosage form. A publicly available water-honey product also specifies its strength by the weight of one hundred pills. Superficially similar units can conceal different manufacture, honey content, and mass per pill. Do not transfer a pill count, sachet weight, or daily frequency from one product to another, and do not estimate a dose from color or size. Directions must come from the current insert for the product in hand and from the prescriber.

Product inserts can contain contraindications and precautions more specific than the monograph. One public water-honey pill insert contraindicates use in traditional patterns described as yin deficiency with exuberant fire or ascendant liver yang, advises administration after food, and warns against excessive or prolonged use because the formula contains cinnabar. This shows why each product must be checked rather than why every statement from one manufacturer can be generalized. Follow any storage, package-removal, supervision, and other directions on the actual label. “Adverse reactions unknown” does not mean that absence of harm has been demonstrated.

Traditional claims and symptom differentiation

“Cold deficiency of heart qi” and “supplementing qi, nourishing blood, and calming the spirit” are traditional pattern and function terms. Palpitations, vivid dreams, or forgetfulness alone are not enough for self-selection. Difficulty initiating or maintaining sleep, early waking, and daytime impairment can arise from inadequate sleep opportunity, circadian misalignment, anxiety or depression, pain, menopausal symptoms, thyroid disease, caffeine, alcohol, or medicines. Palpitations may also reflect an arrhythmia, anemia, infection, or a metabolic disorder and should not be relabeled as “deficiency cold” without assessment.

Persistent palpitations or palpitations accompanied by chest pain, fainting, or breathlessness require prompt medical care. Loud snoring, witnessed breathing pauses, nocturnal choking, morning headache, restless-legs symptoms, unusual sleep behaviors, a short period of marked activation or reduced need for sleep, progressive cognitive change, and thoughts of self-harm also need appropriate evaluation. Baizi Yangxin Pills does not replace electrocardiography, testing for anemia or thyroid disease, sleep-apnea testing, or psychiatric emergency care.

Interpreting the clinical evidence

A systematic review of the broad category of “nourishing the heart and calming the spirit” therapy pooled many different formulas and reported improvement in questionnaires and some sleep measures. The prescriptions were not all the same Baizi Yangxin Pills product. A broader review of Chinese herbal medicine for insomnia likewise found very high heterogeneity and frequent deficiencies in randomization, allocation concealment, and blinding, and could not determine a typical herbal-medicine effect. These findings provide research context but do not show that this finished product is equivalent or superior to placebo or standard treatment.

Retrievable small studies often combine Baizi Yangxin Pills with a modified Guipi decoction or use the pill as a comparator for another patent medicine. A combination design cannot isolate this product's contribution, and selected older populations and traditional patterns limit generalization. Animal sedation experiments, network pharmacology, and studies of arborvitae seed or sour jujube seed also cannot establish the net clinical benefit of the thirteen-ingredient finished product. Evidence assessment must match the exact formula, dosage form, manufacturer, batch, duration, comparator, and outcome, and must separate a subjective “total response,” PSQI, sleep diaries, and objective sleep architecture.

Cinnabar, mercury exposure, and prohibited combinations

The current pharmacopoeial formula and the reviewed public product both contain cinnabar, a source of mercuric sulfide. Mercuric sulfide is poorly soluble and is generally absorbed less by mouth than mercuric chloride or methylmercury, so different mercury species should not be equated from total mercury alone. Lower absorption, however, is not absence of toxicity. Dose, duration, processing, heating, combined exposures, and liver and kidney function affect risk; excessive or prolonged use can increase the possibility of mercury accumulation and renal or neurologic injury.

Do not increase the dose or duration, heat or decoct the medicine, burn or fumigate its powder, repurpose it for topical use, or stack it with other traditional medicines containing cinnabar, mercury, or undisclosed ingredients. The reviewed water-honey pill insert specifically prohibits coadministration with bromide- or iodide-containing medicines. For any product with this name, check its own label and disclose all prescriptions, nonprescription medicines, supplements, and topical products to a clinician or pharmacist. Do not disregard product warnings in hepatic or renal impairment.

Priority populations, interactions, and adverse signals

One public insert directs pregnant or breastfeeding people, children, and older adults to use the product only on medical advice, with adult supervision for children. This is not confirmation of long-term safety in these populations. People planning pregnancy, those who are pregnant or breastfeeding, and those with liver or kidney disease, multiple conditions, or polypharmacy should not self-treat. Honey pills also contain processed honey and other excipients; people with diabetes, allergy, or a need to control sugars must check the exact excipient list and quantity rather than reading only the thirteen medicinal ingredients.

Combining this medicine with hypnotics, anxiolytics, antidepressants, antiseizure medicines, alcohol, or sedating antihistamines may increase somnolence, dizziness, and falls. Anticoagulant, antiplatelet, and narrow-therapeutic-index therapy also warrants item-by-item review. Stop use and seek care according to severity for rash, swelling of the face, lips, or tongue, difficulty breathing, persistent gastrointestinal symptoms, unusual somnolence, tremor, altered sensation, marked weakness, behavioral or memory change, or changes in urine volume or appearance. Do not induce vomiting or use unverified “mercury detox” products or chelators.

Time-limited use, quality checks, and reassessment

After a professional confirms the exact product and its suitability, use should have a defined time boundary set by the label or prescription. Do not add doses after one poor night or repeatedly renew it without review. Before purchase and administration, check the approval number, batch, expiry, seal, storage conditions, and pill appearance. Do not use pills that are damp, stuck together, moldy, abnormally discolored or odorous, in damaged packaging, or of uncertain origin. A sleep diary that records administration time, sleep onset, awakenings, rising time, daytime function, palpitations, and adverse effects is more useful for review than one night's impression.

No improvement by the specified review point, recurrent symptoms whenever use stops, or new cardiac, neurologic, or renal symptoms calls for renewed cause-based assessment rather than another self-directed cycle. Multicomponent cognitive behavioral therapy for insomnia is first-line treatment for chronic insomnia in adults; sleep-hygiene advice alone is not a substitute for the full treatment. Suspected obstructive sleep apnea needs appropriate sleep testing. Baizi Yangxin Pills should not be claimed to cure insomnia, enhance memory in healthy people, regulate heart rhythm, treat anxiety, depression, or sleep apnea, or replace a treatment shown to be effective after proper evaluation.